Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 11, Pages 1445-1456
Publisher
Springer Nature
Online
2015-07-13
DOI
10.1038/onc.2015.211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The interaction of anticancer therapies with tumor-associated macrophages
- (2015) Alberto Mantovani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
- (2014) L. Volk-Draper et al. CANCER RESEARCH
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- Serum Amyloid A3 Binds MD-2 To Activate p38 and NF- B Pathways in a MyD88-Dependent Manner
- (2013) A. Deguchi et al. JOURNAL OF IMMUNOLOGY
- TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
- (2013) S. Rajput et al. MOLECULAR CANCER THERAPEUTICS
- CyClus: A fast, comprehensive cylindrical interface approximation clustering/reranking method for rigid-body protein-protein docking decoys
- (2013) Satoshi Omori et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci
- (2013) Sachie Hiratsuka et al. Nature Communications
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Induction of nuclear factor-κB responses by the S100A9 protein is Toll-like receptor-4-dependent
- (2012) Matteo Riva et al. IMMUNOLOGY
- Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
- (2012) Durba Pal et al. NATURE MEDICINE
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2
- (2012) U. Ohto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases 1 Integrin-Mediated Cell Adhesion and Liver Metastasis
- (2011) R. Y. C. Hsu et al. CANCER RESEARCH
- Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands
- (2011) Chao Shi et al. IMMUNITY
- S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression
- (2011) M. Ichikawa et al. MOLECULAR CANCER RESEARCH
- Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis
- (2011) T Tomita et al. ONCOGENE
- Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library
- (2011) Brian G. Pierce et al. PLoS One
- Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21
- (2011) R. Merline et al. Science Signaling
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
- (2010) T. Kitamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
- (2010) H. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
- (2009) M. J. Szczepanski et al. CANCER RESEARCH
- The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
- (2009) Jan M. Ehrchen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
- (2009) Per Björk et al. PLOS BIOLOGY
- RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
- (2008) Olga Turovskaya et al. CARCINOGENESIS
- S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
- (2008) S. Ghavami et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase
- (2008) Sachie Hiratsuka et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search